Novacyt S.A. (LON:NCYT – Get Free Report) shares hit a new 52-week high during trading on Monday . The company traded as high as GBX 137 ($1.75) and last traded at GBX 118 ($1.51), with a volume of 6894893 shares changing hands. The stock had previously closed at GBX 96 ($1.23).
Novacyt Stock Up 22.9 %
The company has a quick ratio of 4.46, a current ratio of 2.92 and a debt-to-equity ratio of 15.71. The firm has a market cap of £83.34 million, a P/E ratio of -246.15 and a beta of -1.97. The stock’s 50-day simple moving average is GBX 49.52 and its 200 day simple moving average is GBX 52.73.
About Novacyt
Novacyt SA, together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments.
Featured Stories
- Five stocks we like better than Novacyt
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 2 Option Strategies to Maximize Profits in a Bear Market
- Transportation Stocks Investing
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for Novacyt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novacyt and related companies with MarketBeat.com's FREE daily email newsletter.
